Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture-Reference-Cited by-同舟云学术

Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture

Author:

Kim Seoyoung C¹²,Kim Dae Hyun¹³,Mogun Helen¹,Eddings Wesley¹,Polinski Jennifer M¹⁴,Franklin Jessica M¹,Solomon Daniel H¹²

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics; Brigham and Women's Hospital; Boston MA USA

2. Division of Rheumatology, Immunology and Allergy; Brigham and Women's Hospital; Boston MA USA

3. Gerontology Division; Beth Israel Deaconess Medical Center; Boston MA USA

4. CVS Caremark; Woonsocket RI USA

Funder

National Institutes of Health

Paul B. Beeson Clinical Scientist Development Award in Aging

American Federation for Aging Research

John A. Hartford Foundation

Atlantic Philanthropies

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. 2013 http://nof.org/files/nof/public/content/file/344/upload/159.pdf

4. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150676.htm

5. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm101551.htm

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献